Lianzi Wang

Shanghai Jiao Tong University

Papers

1

Total Citations

21

H-Index

1

About

Dr. Lianzi Wang is a pioneering researcher at the intersection of artificial intelligence and mental health, with a primary focus on developing and validating AI-assisted interventions for psychiatric disorders. Her most significant contribution to date is the design and protocol for a prospective, national multicenter randomized controlled trial examining the efficacy of AI-assisted psychotherapy for patients with anxiety disorders—the most prevalent psychiatric condition in China. This landmark 2022 study, which has already garnered 21 citations, addresses a critical gap in mental health care by proposing a scalable solution to the chronic shortage of psychotherapeutic resources. Dr. Wang’s work is notable for its rigorous methodological framework, combining cutting-edge AI technology with evidence-based therapeutic approaches to enhance treatment accessibility and effectiveness. Her research holds profound implications for transforming mental health delivery systems, particularly in resource-limited settings, and positions her as a leading voice in the emerging field of digital psychiatry. Through her innovative trial design, Dr. Wang is paving the way for a new era of technology-enhanced mental health care that could benefit millions of patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy of Artificial Intelligence-Assisted Psychotherapy in Patients With Anxiety Disorders: A Prospective, National Multicenter Randomized Controlled Trial Protocol
21 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Shanghai Jiao Tong University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago